DCM
GILD icon

Driehaus Capital Management’s Gilead Sciences GILD Stock Holding History

Driehaus Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,085
Closed -$569K – 389
2026
Q1 		$569K Sell
4,085
-948
-19% -$133K ﹤0.01% 333
2025
Q4 		$618K Buy
+5,033
New +$612K ﹤0.01% 366
2024
Q1 		– Sell
-2,513
Closed -$204K – 410
2023
Q4 		$204K Buy
+2,513
New +$196K ﹤0.01% 373
2022
Q1 		– Sell
-3,444
Closed -$250K – 409
2021
Q4 		$250K Buy
+3,444
New +$237K ﹤0.01% 358
2020
Q2 		– Sell
-31,300
Closed -$2.34M – 425
2020
Q1 		$2.34M Buy
+31,300
New +$2.16M 0.08% 220
2014
Q4 		– Sell
-44,292
Closed -$4.71M – 527
2014
Q3 		$4.71M Sell
44,292
-86,872
-66% -$8.51M 0.18% 155
2014
Q2 		$10.9M Sell
131,164
-130,082
-50% -$10.1M 0.35% 57
2014
Q1 		$18.5M Buy
261,246
+11,153
+4% +$875K 0.58% 32
2013
Q4 		$18.8M Buy
250,093
+97,410
+64% +$6.78M 0.68% 27
2013
Q3 		$9.6M Buy
152,683
+7,732
+5% +$462K 0.37% 83
2013
Q2 		$7.42M Buy
+144,951
New +$7.56M 0.32% 99

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Driehaus Capital Management's GILD Position: Q2 2026 in Review

Driehaus Capital Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 4,085 shares — an estimated $569K sold.

Driehaus Capital Management first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $18.8M in Q4 2013. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Driehaus Capital Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Driehaus Capital Management sold 4,085 Gilead Sciences shares in Q2 2026, an estimated $569K.
  • Driehaus Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
  • Driehaus Capital Management's Gilead Sciences position peaked at $18.8M in Q4 2013.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.